Cargando…
A quantum chemical approach representing a new perspective concerning agonist and antagonist drugs in the context of schizophrenia and Parkinson’s disease
Schizophrenia and Parkinson’s disease can be controlled with dopamine antagonists and agonists. In order to improve the understanding of the reaction mechanism of these drugs, in this investigation we present a quantum chemical study of 20 antagonists and 10 agonists. Electron donor acceptor capacit...
Autores principales: | Martínez, Ana, Ibarra, Ilich A., Vargas, Rubicelia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6907805/ https://www.ncbi.nlm.nih.gov/pubmed/31830046 http://dx.doi.org/10.1371/journal.pone.0224691 |
Ejemplares similares
-
New information of dopaminergic agents based on quantum chemistry calculations
por: Goode-Romero, Guillermo, et al.
Publicado: (2020) -
Non-conventional interactions of N3 inhibitor with the main protease of SARS-CoV and SARS-CoV-2
por: García-Gutiérrez, Ponciano, et al.
Publicado: (2021) -
Flavonoids as aryl hydrocarbon receptor agonists/antagonists: effects of structure and cell context.
por: Zhang, Shu, et al.
Publicado: (2003) -
Problemas de Fisicoquímica I para ciencias biológicas y de la salud
por: Vargas Fosada, Rubicelia
Publicado: (1995) -
T40. GPR52 AGONISTS REPRESENT A NOVEL APPROACH TO TREAT UNMET MEDICAL NEED IN SCHIZOPHRENIA
por: Grottick, Andrew J, et al.
Publicado: (2018)